Feasibility of intraprocedural integration of cardiac CT to guide left ventricular lead implantation for CRT upgrades.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
03 2021
Historique:
received: 08 10 2020
revised: 19 12 2020
accepted: 17 01 2021
pubmed: 24 1 2021
medline: 10 8 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

Optimal positioning of the left ventricular (LV) lead is an important determinant of cardiac resynchronization therapy (CRT) response. Evaluate the feasibility of intraprocedural integration of cardiac computed tomography (CT) to guide LV lead implantation for CRT upgrades. Patients undergoing LV lead upgrade underwent ECG-gated cardiac CT dyssynchrony and LV scar assessment. Target American Heart Association segment selection was determined using latest non-scarred mechanically activating segments overlaid onto real-time fluoroscopy with image co-registration to guide optimal LV lead implantation. Hemodynamic validation was performed using a pressure wire in the LV cavity (dP/dt 18 patients (male 94%, 55.6% ischemic cardiomyopathy) with RV pacing burden 60.0 ± 43.7% and mean QRS duration 154 ± 30 ms underwent cardiac CT. 10/10 ischemic patients had CT evidence of scar and these segments were excluded as targets. Seventeen out of 18 (94%) patients underwent successful LV lead implantation with delivery to the CT target segment in 15 out of 18 (83%) of patients. Acute hemodynamic response (dP/dt Intraprocedural integration of cardiac CT to guide optimal LV lead placement is feasible with superior hemodynamics when pacing in CT target segments and favorable volumetric response rates, despite a high proportion of patients with ischemic cardiomyopathy. Multicentre, randomized controlled studies are needed to evaluate whether intraprocedural integration of cardiac CT is superior to standard care.

Sections du résumé

BACKGROUND
Optimal positioning of the left ventricular (LV) lead is an important determinant of cardiac resynchronization therapy (CRT) response.
OBJECTIVE
Evaluate the feasibility of intraprocedural integration of cardiac computed tomography (CT) to guide LV lead implantation for CRT upgrades.
METHODS
Patients undergoing LV lead upgrade underwent ECG-gated cardiac CT dyssynchrony and LV scar assessment. Target American Heart Association segment selection was determined using latest non-scarred mechanically activating segments overlaid onto real-time fluoroscopy with image co-registration to guide optimal LV lead implantation. Hemodynamic validation was performed using a pressure wire in the LV cavity (dP/dt
RESULTS
18 patients (male 94%, 55.6% ischemic cardiomyopathy) with RV pacing burden 60.0 ± 43.7% and mean QRS duration 154 ± 30 ms underwent cardiac CT. 10/10 ischemic patients had CT evidence of scar and these segments were excluded as targets. Seventeen out of 18 (94%) patients underwent successful LV lead implantation with delivery to the CT target segment in 15 out of 18 (83%) of patients. Acute hemodynamic response (dP/dt
CONCLUSION
Intraprocedural integration of cardiac CT to guide optimal LV lead placement is feasible with superior hemodynamics when pacing in CT target segments and favorable volumetric response rates, despite a high proportion of patients with ischemic cardiomyopathy. Multicentre, randomized controlled studies are needed to evaluate whether intraprocedural integration of cardiac CT is superior to standard care.

Identifiants

pubmed: 33484216
doi: 10.1111/jce.14896
pmc: PMC8647921
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

802-812

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/91/31812
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT203148/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.

Références

IEEE Trans Med Imaging. 2017 Nov;36(11):2366-2375
pubmed: 28678701
Europace. 2020 Feb 1;22(2):298
pubmed: 31504436
Circ Cardiovasc Imaging. 2012 Mar;5(2):243-50
pubmed: 22342945
Europace. 2019 Apr 1;21(4):626-635
pubmed: 30590434
Europace. 2019 Sep 1;21(9):1369-1377
pubmed: 31274152
J Am Coll Cardiol. 2008 Oct 21;52(17):1402-9
pubmed: 18940531
J Cardiovasc Magn Reson. 2014 Aug 01;16:58
pubmed: 25084814
J Am Coll Cardiol. 2011 Sep 6;58(11):1128-36
pubmed: 21884950
J Cardiovasc Comput Tomogr. 2015 Jul-Aug;9(4):313-20
pubmed: 25977115
JACC Clin Electrophysiol. 2016 Dec;2(7):799-809
pubmed: 28066827
JACC Cardiovasc Imaging. 2008 Nov;1(6):772-81
pubmed: 19212461
Europace. 2018 Oct 1;20(10):1630-1637
pubmed: 29377984
J Cardiovasc Electrophysiol. 2021 Mar;32(3):802-812
pubmed: 33484216
Heart Rhythm. 2017 Sep;14(9):1364-1372
pubmed: 28479514
JACC Cardiovasc Imaging. 2014 Dec;7(12):1239-48
pubmed: 25440593
Heart Rhythm. 2018 Aug;15(8):1206-1213
pubmed: 29572087
N Engl J Med. 2013 Apr 25;368(17):1585-93
pubmed: 23614585
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18
pubmed: 22405632
JACC Clin Electrophysiol. 2017 Aug;3(8):803-814
pubmed: 29759775
ESC Heart Fail. 2019 Oct;6(5):909-920
pubmed: 31400060
Heart Rhythm. 2012 Sep;9(9):1524-76
pubmed: 22939223
Eur J Heart Fail. 2016 Nov;18(11):1365-1374
pubmed: 27087019

Auteurs

Justin Gould (J)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Baldeep S Sidhu (BS)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Benjamin J Sieniewicz (BJ)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Bradley Porter (B)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Angela W C Lee (AWC)

School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Orod Razeghi (O)

School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Jonathan M Behar (JM)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Vishal Mehta (V)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Mark K Elliott (MK)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Daniel Toth (D)

School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Ulrike Haberland (U)

Medical Imaging Technologies, Siemens Healthineers, Malvern, Pennsylvania, USA.

Reza Razavi (R)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Ronak Rajani (R)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Steven Niederer (S)

School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Christopher A Rinaldi (CA)

Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
School of Biomedical Engineering and Imaging Sciences, King's College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH